MIRA Pharma (MIRA) - Multiplikator Forward P/S

MIRA Pharmaceuticals is developing the MIRA-55 synthetic cannabinoid ecosystem by creating closed treatment protocols. The company adheres to ESG standards for emission filtration and research ethics, targeting the growing demand for non-opioid analgesics. The current forward P/S ratio helps filter out market noise, while the value represents the current valuation metric for expected sales one year forward.

MIRA (MIRA Pharmaceuticals Inc.) riwayat Rega forward marang dodolan saka 04.07.2022 nganti 15.11.2026

Rincian metrik komprehensif lan analitis MIRA Pharmaceuticals, Inc. (MIRA)

- rega pasar lan target rega analis:

Bagan rega MIRA Pharmaceuticals|MIRA - Konsensus nilai wajar

- indikator kapitalisasi pasar:

Kapitalisasi pasar MIRA Pharmaceuticals|MIRA - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi saben Saham MIRA Pharmaceuticals|MIRA - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku mirapharmaceuticals.com|MIRA - Nilai Total Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Total Utang marang Modal MIRA Pharmaceuticals|MIRA - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal MIRA Pharmaceuticals Inc.|MIRA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku MIRA Pharmaceuticals Inc.|MIRA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MIRA Pharmaceuticals|Rasio cepet mirapharmaceuticals.com

- indikator pendapatan resik lan kelipatan nilai:

MIRA - Bathi resik|Proyeksi bathi mangsa ngarep MIRA Pharmaceuticals|MIRA - Koefisien rega marang bathi|Pangali Forward P/E MIRA Pharmaceuticals, Inc.|MIRA - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MIRA Pharmaceuticals|MIRA - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan MIRA Pharmaceuticals|MIRA - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan mirapharmaceuticals.com|MIRA - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep MIRA Pharmaceuticals

- statistik dodolan lan pendapatan perusahaan:

MIRA - Dodolan perusahaan|Prakiraan volume dodolan MIRA Pharmaceuticals Inc.|MIRA - Multiplikator P/S|Rasio rega marang prakiraan pendapatan MIRA Pharmaceuticals, Inc.|MIRA - Wutah dodolan YoY sajrone rolas wulan kepungkur

Analisis fundamental perusahaan:MIRA (MIRA Pharmaceuticals, Inc.)

The selection of defensive assets is based on a business's ability to generate revenue amid rising borrowing costs. For MIRA Pharmaceuticals (MIRA), given its high preclinical research expenditures and the risk of testing delays, the forward P/S trend reflects the market valuation of future sales per share. This indicator measures capital's willingness to invest in the company's expected earnings, signaling the stock's sensitivity to operational shocks.

Pesaing wigati

Multiplikator Forward P/S INDV (Indivior PLC)|Collegium Corp - Rasio rega marang prakiraan pendapatan|CRON - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CGC|HITI (High Tide) - Multiplikator forward rega marang pendapatan|Aurora Cannabis (ACB) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan ACHV|Rasio rega marang prakiraan pendapatan SKYE|Rasio rega marang prakiraan pendapatan Anebulo Pharmaceuticals Inc (ANEB)|Multiplikator Forward P/S InterCure Ltd (INCR)|Rasio rega marang prakiraan pendapatan nutriband.com NTRB|Rega forward marang dodolan NSRX|IGC Pharma, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Flora Growth Corp.|IMCC: Multiplikator Forward P/S|Adial - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Artelo Biosciences, Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ensysce.com ENSC|Multiplikator Forward P/S TTNP|GNLN - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S INM (InMed Pharmaceuticals Inc)|Rega forward marang dodolan AKAN|Enveric Biosciences Inc - Multiplikator Forward P/S|Prakiraan rega marang pendapatan Bright Green Corp. (BGXX)|Hempacco Co., Inc. (HPCO) - Rasio rega marang prakiraan pendapatan